Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 676

1.

Neural mechanisms of perceptual decision-making and their link to neuropsychiatric symptoms in multiple sclerosis.

Weygandt M, Behrens J, Brasanac J, Söder E, Meyer-Arndt L, Wakonig K, Ritter K, Brandt AU, Bellmann-Strobl J, Gold SM, Haynes JD, Paul F.

Mult Scler Relat Disord. 2019 May 30;33:139-145. doi: 10.1016/j.msard.2019.05.025. [Epub ahead of print]

PMID:
31195338
2.

Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy.

Klehmet J, Beutner S, Hoffmann S, Dornauer M, Paul F, Reilmann R, Brandt AU, Meisel A.

BMC Neurol. 2019 Jun 8;19(1):118. doi: 10.1186/s12883-019-1339-x.

3.

Olfactory and Gustatory Dysfunction in Patients With Autoimmune Encephalitis.

Geran R, Uecker FC, Prüss H, Haeusler KG, Paul F, Ruprecht K, Harms L, Schmidt FA.

Front Neurol. 2019 May 14;10:480. doi: 10.3389/fneur.2019.00480. eCollection 2019.

4.

Vision and Vision-Related Measures in Progressive Multiple Sclerosis.

Backner Y, Petrou P, Glick-Shames H, Raz N, Zimmermann H, Jost R, Scheel M, Paul F, Karussis D, Levin N.

Front Neurol. 2019 May 3;10:455. doi: 10.3389/fneur.2019.00455. eCollection 2019.

5.

Attack-related damage of thalamic nuclei in neuromyelitis optica spectrum disorders.

Papadopoulou A, Oertel FC, Gaetano L, Kuchling J, Zimmermann H, Chien C, Siebert N, Asseyer S, Bellmann-Strobl J, Ruprecht K, Chakravarty MM, Scheel M, Magon S, Wuerfel J, Paul F, Brandt AU.

J Neurol Neurosurg Psychiatry. 2019 May 24. pii: jnnp-2018-320249. doi: 10.1136/jnnp-2018-320249. [Epub ahead of print]

PMID:
31127016
6.

Variational selection of features for molecular kinetics.

Scherer MK, Husic BE, Hoffmann M, Paul F, Wu H, Noé F.

J Chem Phys. 2019 May 21;150(19):194108. doi: 10.1063/1.5083040.

PMID:
31117766
7.

MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing.

Keren-Shaul H, Kenigsberg E, Jaitin DA, David E, Paul F, Tanay A, Amit I.

Nat Protoc. 2019 Jun;14(6):1841-1862. doi: 10.1038/s41596-019-0164-4. Epub 2019 May 17.

PMID:
31101904
8.

Active contour method for ILM segmentation in ONH volume scans in retinal OCT.

Gawlik K, Hausser F, Paul F, Brandt AU, Kadas EM.

Biomed Opt Express. 2018 Nov 28;9(12):6497-6518. doi: 10.1364/BOE.9.006497. eCollection 2018 Dec 1.

9.

Identification of kinetic order parameters for non-equilibrium dynamics.

Paul F, Wu H, Vossel M, de Groot BL, Noé F.

J Chem Phys. 2019 Apr 28;150(16):164120. doi: 10.1063/1.5083627.

PMID:
31042914
10.

Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis.

Gasperi C, Salmen A, Antony G, Bayas A, Heesen C, Kümpfel T, Linker RA, Paul F, Stangel M, Tackenberg B, Bergh FT, Warnke C, Weber F, Wiendl H, Wildemann B, Zettl UK, Ziemann U, Zipp F, Tumani H, Gold R, Hemmer B; German Competence Network of Multiple Sclerosis.

JAMA Neurol. 2019 Apr 29. doi: 10.1001/jamaneurol.2019.0905. [Epub ahead of print]

PMID:
31034002
11.

Increased Retention of Gadolinium in the Inflamed Brain After Repeated Administration of Gadopentetate Dimeglumine: A Proof-of-Concept Study in Mice Combining ICP-MS and Micro- and Nano-SR-XRF.

Wang S, Hesse B, Roman M, Stier D, Castillo-Michel H, Cotte M, Suuronen JP, Lagrange A, Radbruch H, Paul F, Taupitz M, Schellenberger E, Sack I, Infante-Duarte C.

Invest Radiol. 2019 Apr 26. doi: 10.1097/RLI.0000000000000571. [Epub ahead of print]

PMID:
31033673
12.

Standardization of T1w/T2w Ratio Improves Detection of Tissue Damage in Multiple Sclerosis.

Cooper G, Finke C, Chien C, Brandt AU, Asseyer S, Ruprecht K, Bellmann-Strobl J, Paul F, Scheel M.

Front Neurol. 2019 Apr 9;10:334. doi: 10.3389/fneur.2019.00334. eCollection 2019.

13.

The mechanism of RNA base fraying: Molecular dynamics simulations analyzed with core-set Markov state models.

Pinamonti G, Paul F, Noé F, Rodriguez A, Bussi G.

J Chem Phys. 2019 Apr 21;150(15):154123. doi: 10.1063/1.5083227.

PMID:
31005065
14.

MAPK pathway and B cells overactivation in multiple sclerosis revealed by phosphoproteomics and genomic analysis.

Kotelnikova E, Kiani NA, Messinis D, Pertsovskaya I, Pliaka V, Bernardo-Faura M, Rinas M, Vila G, Zubizarreta I, Pulido-Valdeolivas I, Sakellaropoulos T, Faigle W, Silberberg G, Masso M, Stridh P, Behrens J, Olsson T, Martin R, Paul F, Alexopoulos LG, Saez-Rodriguez J, Tegner J, Villoslada P.

Proc Natl Acad Sci U S A. 2019 May 7;116(19):9671-9676. doi: 10.1073/pnas.1818347116. Epub 2019 Apr 19.

PMID:
31004050
15.

Association of Occupational Pesticide Exposure With Immunochemotherapy Response and Survival Among Patients With Diffuse Large B-Cell Lymphoma.

Lamure S, Carles C, Aquereburu Q, Quittet P, Tchernonog E, Paul F, Jourdan E, Waultier A, Defez C, Belhadj I, Sanhes L, Burcheri S, Donadio D, Exbrayat C, Saad A, Labourey JL, Baldi I, Cartron G, Fabbro-Peray P.

JAMA Netw Open. 2019 Apr 5;2(4):e192093. doi: 10.1001/jamanetworkopen.2019.2093.

16.

Global glacier mass changes and their contributions to sea-level rise from 1961 to 2016.

Zemp M, Huss M, Thibert E, Eckert N, McNabb R, Huber J, Barandun M, Machguth H, Nussbaumer SU, Gärtner-Roer I, Thomson L, Paul F, Maussion F, Kutuzov S, Cogley JG.

Nature. 2019 Apr;568(7752):382-386. doi: 10.1038/s41586-019-1071-0. Epub 2019 Apr 8.

PMID:
30962533
17.

Nightmares do result in psychophysiological arousal: A multimeasure ambulatory assessment study.

Paul F, Alpers GW, Reinhard I, Schredl M.

Psychophysiology. 2019 Jul;56(7):e13366. doi: 10.1111/psyp.13366. Epub 2019 Mar 30.

PMID:
30927477
18.

Quantitative 7T MRI does not detect occult brain damage in neuromyelitis optica.

Pasquier B, Borisow N, Rasche L, Bellmann-Strobl J, Ruprecht K, Niendorf T, Derfuss TJ, Wuerfel J, Paul F, Sinnecker T.

Neurol Neuroimmunol Neuroinflamm. 2019 Mar 7;6(3):e541. doi: 10.1212/NXI.0000000000000541. eCollection 2019 May.

19.

Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study.

Olesen MN, Soelberg K, Debrabant B, Nilsson AC, Lillevang ST, Grauslund J, Brandslund I, Madsen JS, Paul F, Smith TJ, Jarius S, Asgari N.

J Neuroinflammation. 2019 Mar 11;16(1):59. doi: 10.1186/s12974-019-1440-5.

20.

Optimal intereye difference thresholds by optical coherence tomography in multiple sclerosis: An international study.

Nolan-Kenney RC, Liu M, Akhand O, Calabresi PA, Paul F, Petzold A, Balk L, Brandt AU, Martínez-Lapiscina EH, Saidha S, Villoslada P, Al-Hassan AA, Behbehani R, Frohman EM, Frohman T, Havla J, Hemmer B, Jiang H, Knier B, Korn T, Leocani L, Papadopoulou A, Pisa M, Zimmermann H, Galetta SL, Balcer LJ; International Multiple Sclerosis Visual System Consortium.

Ann Neurol. 2019 May;85(5):618-629. doi: 10.1002/ana.25462. Epub 2019 Apr 10.

PMID:
30851125
21.

Leptomeningeal and Intraparenchymal Blood Barrier Disruption in a MOG-IgG-Positive Patient.

Mohseni SH, Skejoe HPB, Wuerfel J, Paul F, Reindl M, Jarius S, Asgari N.

Case Rep Neurol Med. 2018 Dec 9;2018:1365175. doi: 10.1155/2018/1365175. eCollection 2018.

22.
23.

The use of magnetic resonance imaging in the diagnosis of paediatric transverse myelitis.

Paul F.

Dev Med Child Neurol. 2019 Feb 5. doi: 10.1111/dmcn.14171. [Epub ahead of print] No abstract available.

PMID:
30720201
24.

Less Is More - Estimation of the Number of Strides Required to Assess Gait Variability in Spatially Confined Settings.

Kroneberg D, Elshehabi M, Meyer AC, Otte K, Doss S, Paul F, Nussbaum S, Berg D, Kühn AA, Maetzler W, Schmitz-Hübsch T.

Front Aging Neurosci. 2019 Jan 21;10:435. doi: 10.3389/fnagi.2018.00435. eCollection 2018.

25.

Differential Impact According to Mission's Operational Intensity on Psychoactive Substance Use: A Retrospective Cohort of French Male Army Service Members.

Marchi J, Mayet A, Chamonaz C, de Laval F, Paul F, Marimoutou C.

Subst Use Misuse. 2019;54(5):841-851. doi: 10.1080/10826084.2018.1547908. Epub 2019 Jan 16.

PMID:
30648459
26.

Chi3l3 induces oligodendrogenesis in an experimental model of autoimmune neuroinflammation.

Starossom SC, Campo Garcia J, Woelfle T, Romero-Suarez S, Olah M, Watanabe F, Cao L, Yeste A, Tukker JJ, Quintana FJ, Imitola J, Witzel F, Schmitz D, Morkel M, Paul F, Infante-Duarte C, Khoury SJ.

Nat Commun. 2019 Jan 15;10(1):217. doi: 10.1038/s41467-018-08140-7.

27.

Competency-based Professional Advancement Model for Advanced Practice RNs.

Paul F, Abecassis L, Freiberger D, Hamilton S, Kelly P, Klements E, LaGrasta C, Lemire L, OʼDonnell E, Patisteas E, Phinney C, Conwell K, Saia T, Whelan K, Wood LJ, OʼBrien P.

J Nurs Adm. 2019 Feb;49(2):66-72. doi: 10.1097/NNA.0000000000000719.

PMID:
30640314
28.

N2 year in review and message from the editor to our reviewers.

Dalmau J, Kolson DL, Paul F, Zamvil SS.

Neurol Neuroimmunol Neuroinflamm. 2018 Dec 19;6(1):e525. doi: 10.1212/NXI.0000000000000525. eCollection 2019 Jan. No abstract available.

29.

CSF-Progranulin and Neurofilament Light Chain Levels in Patients With Radiologically Isolated Syndrome-Sign of Inflammation.

Pawlitzki M, Sweeney-Reed CM, Bittner D, Lux A, Vielhaber S, Schreiber S, Paul F, Neumann J.

Front Neurol. 2018 Dec 18;9:1075. doi: 10.3389/fneur.2018.01075. eCollection 2018.

30.

Novel uses of retinal imaging with optical coherence tomography in multiple sclerosis.

Oertel FC, Zimmermann HG, Brandt AU, Paul F.

Expert Rev Neurother. 2018 Dec 27:1-13. doi: 10.1080/14737175.2019.1559051. [Epub ahead of print]

PMID:
30587061
31.

Infusion-related reactions to rituximab: frequency, mechanisms and predictors.

Paul F, Cartron G.

Expert Rev Clin Immunol. 2019 Apr;15(4):383-389. doi: 10.1080/1744666X.2019.1562905. Epub 2019 Jan 11.

PMID:
30580638
32.

Gadolinium in human brain sections and colocalization with other elements.

El-Khatib AH, Radbruch H, Trog S, Neumann B, Paul F, Koch A, Linscheid MW, Jakubowski N, Schellenberger E.

Neurol Neuroimmunol Neuroinflamm. 2018 Oct 19;6(1):e515. doi: 10.1212/NXI.0000000000000515. eCollection 2019 Jan. No abstract available.

33.

Metabolic, Mental and Immunological Effects of Normoxic and Hypoxic Training in Multiple Sclerosis Patients: A Pilot Study.

Mähler A, Balogh A, Csizmadia I, Klug L, Kleinewietfeld M, Steiniger J, Šušnjar U, Müller DN, Boschmann M, Paul F.

Front Immunol. 2018 Nov 29;9:2819. doi: 10.3389/fimmu.2018.02819. eCollection 2018.

34.

Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion length and presence of symptomatic brain lesions.

Mealy MA, Mossburg SE, Kim SH, Messina S, Borisow N, Lopez-Gonzalez R, Ospina JP, Scheel M, Yeshokumar AK, Awad A, Leite MI, Arango JJ, Paul F, Palace J, Kim HJ, Levy M.

Mult Scler Relat Disord. 2019 Feb;28:64-68. doi: 10.1016/j.msard.2018.12.011. Epub 2018 Dec 9.

PMID:
30554040
35.

Pro-inflammatory Monocyte Phenotype and Cell-Specific Steroid Signaling Alterations in Unmedicated Patients With Major Depressive Disorder.

Hasselmann H, Gamradt S, Taenzer A, Nowacki J, Zain R, Patas K, Ramien C, Paul F, Wingenfeld K, Piber D, Gold SM, Otte C.

Front Immunol. 2018 Nov 23;9:2693. doi: 10.3389/fimmu.2018.02693. eCollection 2018.

36.

Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS).

Johnen A, Bürkner PC, Landmeyer NC, Ambrosius B, Calabrese P, Motte J, Hessler N, Antony G, König IR, Klotz L, Hoshi MM, Aly L, Groppa S, Luessi F, Paul F, Tackenberg B, Bergh FT, Kümpfel T, Tumani H, Stangel M, Weber F, Bayas A, Wildemann B, Heesen C, Zettl UK, Zipp F, Hemmer B, Meuth SG, Gold R, Wiendl H, Salmen A; German Competence Network Multiple Sclerosis (KKNMS).

J Neurol. 2019 Feb;266(2):386-397. doi: 10.1007/s00415-018-9142-y. Epub 2018 Dec 4.

37.

The first night effect in multiple sclerosis patients undergoing home-based polysomnography.

Veauthier C, Piper SK, Gaede G, Penzel T, Paul F.

Nat Sci Sleep. 2018 Oct 26;10:337-344. doi: 10.2147/NSS.S176201. eCollection 2018.

38.

Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity.

Chien C, Scheel M, Schmitz-Hübsch T, Borisow N, Ruprecht K, Bellmann-Strobl J, Paul F, Brandt AU.

Mult Scler. 2018 Nov 26:1352458518815596. doi: 10.1177/1352458518815596. [Epub ahead of print]

PMID:
30475082
39.

Targeting interferon activity to dendritic cells enables in vivo tolerization and protection against EAE in mice.

Cauwels A, Van Lint S, Catteeuw D, Pang S, Paul F, Rogge E, Verhee A, Prinz M, Kley N, Uzé G, Tavernier J.

J Autoimmun. 2019 Feb;97:70-76. doi: 10.1016/j.jaut.2018.10.010. Epub 2018 Nov 19.

PMID:
30467068
40.

[Optical Coherence Tomography in Disorders of the Central Nervous System].

Papadopoulou A, Oertel FC, Zimmermann H, Zeitz O, Brandt AU, Paul F.

Klin Monbl Augenheilkd. 2018 Nov;235(11):1242-1258. doi: 10.1055/a-0715-7961. Epub 2018 Nov 20. German.

PMID:
30458564
41.

Author Correction: Comparing Sanger sequencing and high-throughput metabarcoding for inferring photobiont diversity in lichens.

Paul F, Otte J, Schmitt I, Grande FD.

Sci Rep. 2018 Nov 16;8(1):17229. doi: 10.1038/s41598-018-35358-8.

42.

The International Multiple Sclerosis Visual System Consortium: Advancing Visual System Research in Multiple Sclerosis.

Balcer LJ, Balk LJ, Brandt AU, Calabresi PA, Martinez-Lapiscina EH, Nolan RC, Paul F, Petzold A, Saidha S.

J Neuroophthalmol. 2018 Dec;38(4):494-501. doi: 10.1097/WNO.0000000000000732.

PMID:
30418332
43.

Ozanimod for the treatment of relapsing remitting multiple sclerosis.

Rasche L, Paul F.

Expert Opin Pharmacother. 2018 Dec;19(18):2073-2086. doi: 10.1080/14656566.2018.1540592. Epub 2018 Nov 8.

PMID:
30407868
44.

Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis.

Borisow N, Mori M, Kuwabara S, Scheel M, Paul F.

Front Neurol. 2018 Oct 23;9:888. doi: 10.3389/fneur.2018.00888. eCollection 2018. Review.

45.

Racial differences in neuromyelitis optica spectrum disorder.

Kim SH, Mealy MA, Levy M, Schmidt F, Ruprecht K, Paul F, Ringelstein M, Aktas O, Hartung HP, Asgari N, Tsz-Ching JL, Siritho S, Prayoonwiwat N, Shin HJ, Hyun JW, Han M, Leite MI, Palace J, Kim HJ.

Neurology. 2018 Nov 27;91(22):e2089-e2099. doi: 10.1212/WNL.0000000000006574. Epub 2018 Oct 26.

PMID:
30366977
46.

Sex differences in autoimmune disorders of the central nervous system.

Gold SM, Willing A, Leypoldt F, Paul F, Friese MA.

Semin Immunopathol. 2019 Mar;41(2):177-188. doi: 10.1007/s00281-018-0723-8. Epub 2018 Oct 25.

PMID:
30361800
47.

Disease Modification in Multiple Sclerosis by Flupirtine-Results of a Randomized Placebo Controlled Phase II Trial.

Dörr J, Wernecke KD, Würfel J, Bellmann-Strobl J, Siffrin V, Sättler MB, Simons M, Linsa A, Tumani H, Paul F.

Front Neurol. 2018 Oct 9;9:842. doi: 10.3389/fneur.2018.00842. eCollection 2018.

48.

Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions.

Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke KD, Hellwig K, Pache F, Ruprecht K, Havla J, Kümpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Stellmann JP, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Krumbholz M, Zeltner L, Ziemann U, Linker R, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Zettl UK, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C; NEMOS (Neuromyelitis Optica Study Group).

Neurol Neuroimmunol Neuroinflamm. 2018 Sep 26;5(6):e504. doi: 10.1212/NXI.0000000000000504. eCollection 2018 Nov.

49.

Optic nerve head three-dimensional shape analysis.

Yadav SK, Kadas EM, Motamedi S, Polthier K, Haußer F, Gawlik K, Paul F, Brandt A.

J Biomed Opt. 2018 Oct;23(10):1-13. doi: 10.1117/1.JBO.23.10.106004.

PMID:
30315645
50.

Venoplasty in MS: Therapeutic intervention without any evidence.

Paul F, Wattjes MP.

Neurology. 2018 Oct 30;91(18):815-816. doi: 10.1212/WNL.0000000000006419. Epub 2018 Sep 28. No abstract available.

PMID:
30266888

Supplemental Content

Support Center